Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.19T
Market cap1.19T
Price-Earnings ratio
43.51
Price-Earnings ratio43.51
Dividend yield
0.50%
Dividend yield0.50%
Average volume
2.64M
Average volume2.64M
High today
$1,280.00
High today$1,280.00
Low today
$1,257.00
Low today$1,257.00
Open price
$1,274.78
Open price$1,274.78
Volume
1.03M
Volume1.03M
52 Week high
$1,292.65
52 Week high$1,292.65
52 Week low
$685.15
52 Week low$685.15

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,263.09, giving the company a market capitalization of 1.19T. It carries a P/E multiple of 43.51 and pays a dividend yield of 0.50%.

On 2026-08-20, Eli Lilly(LLY) stock traded between a low of $1,257.00 and a high of $1,280.00. Shares are currently priced at $1,263.09, which is +0.5% above the low and -1.3% below the high.

The Eli Lilly(LLY)'s current trading volume is 1.03M, compared to an average daily volume of 2.64M.

During the past year, Eli Lilly(LLY) stock moved between $685.15 at its lowest and $1,292.65 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $685.15 at its lowest and $1,292.65 at its peak.

LLY News

TipRanks 1h
Lilly’s Mirikizumab Breast Milk Study Adds A New Layer To Immunology Safety Data

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

TipRanks 1h
Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

TipRanks 1h
Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
12.1%
Sell
6.1%

More LLY News

Simply Wall St 15h
How Eli Lilly’s Global Vault CRM Rollout At Veeva Systems Has Changed Its Investment Story

Earlier this month, Eli Lilly and Company committed to deploy Veeva Vault CRM globally as part of Veeva’s Vault CRM Suite supporting agentic commercial workflow...

How Eli Lilly’s Global Vault CRM Rollout At Veeva Systems Has Changed Its Investment Story
Simply Wall St 16h
Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's Narrative?

In recent days, Eli Lilly announced multiple R&D agreements, including global rights to AlzeCure’s preclinical Alzheimer’s candidate ACD680 with potential miles...

Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's Narrative?
Nasdaq 21h
Could Eli Lilly Be Worth More Than SpaceX by the End of 2026?

Key Points Eli Lilly is highly profitable and has been growing fast due to its popular GLP-1 drugs. SpaceX's stock went public recently and has been incredibl...

Could Eli Lilly Be Worth More Than SpaceX by the End of 2026?
Investor's Business Daily 21h
Dow Jones Futures: S&P 500, Nasdaq Rise On Treasury Move; Moderna, Merck Spur Big Biopharma Gains

Stock Market Today Dow Jones Futures: S&P 500, Nasdaq Rise On Treasury Move; Moderna, Merck Spur Big Biopharma Gains Licensing Dow Jones futures were little cha...

Dow Jones Futures: S&P 500, Nasdaq Rise On Treasury Move; Moderna, Merck Spur Big Biopharma Gains
TipRanks 1d
Lilly’s LY4086940 Phase 1 Wrap‑Up: Reading the Signals for Obesity and Diabetes Investors

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...

Investor's Business Daily 1d
IBD Stock Of The Day, Hinge, Eyes A Fresh Entry On Earnings-Tied Rally

Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test 8/03/2026 As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings...

IBD Stock Of The Day, Hinge, Eyes A Fresh Entry On Earnings-Tied Rally
24/7 Wall St. 1d
Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold? By Vandita Jadeja Published Aug 19, 12:00PM EDT Quick Read LLY dominates the GLP-1 race with 48% revenue...

Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.